Your browser doesn't support javascript.
loading
Patient perceptions and understanding of obesity related endometrial cancer.
Wilkinson, M; Murphy, S; Sinclair, P; Heneghan, H; le Roux, C W; Brennan, D J.
Afiliação
  • Wilkinson M; Department of Gynaecological Oncology, UCD School of Medicine, Catherine McAuley Research Centre, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Murphy S; Department of Gynaecological Oncology, UCD School of Medicine, Catherine McAuley Research Centre, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Sinclair P; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland.
  • Heneghan H; Metabolic Surgery Unit, St. Vincent's University Hospital, Dublin, Ireland.
  • le Roux CW; University College Dublin, Dublin, Ireland.
  • Brennan DJ; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland.
Gynecol Oncol Rep ; 32: 100545, 2020 May.
Article em En | MEDLINE | ID: mdl-32072005
ABSTRACT
Obesity is the greatest risk factor for endometrial cancer. There is often a lack of recognition amongst patients about this risk. Evidence for weight-loss in the management of endometrial cancer is emerging. This was questionnaire-based study, that examined opinions and attitudes of patients with endometrial cancer and obesity towards obesity as a risk factor for cancer as well as examining their willingness to engage in weight loss interventions as an alternative treatment to endometrial cancer. This survey was conducted in a gynaeoncology out-patient department in Ireland. A total of 45/50 (90%) of questionnaires were completed. The majority of the patients questioned (86.7%; 39/45) agreed that obesity is a disease. Just over half of the cohort (53.3%; 24/45) believed that obesity can cause cancer. Over one-third, 39.9% (18/45) either disagreed or strongly disagreed that obesity is a risk factor for endometrial cancer while 35.5% (16/45) agreed or strongly agreed. Two-thirds (66.6%; 30/45) knew that the greatest amount of weight could be lost through metabolic surgery. Over three-quarters (82.1%; 37/45) of patients surveyed would be willing to engage in a combination of treatments in order to achieve weight-loss should it be proven to have a role in the management of endometrial cancer. This study demonstrates a need for patient education regarding the strong relationship between obesity and endometrial cancer risk. Patients are willing to consider weight loss interventions if they were proven to be as safe and effective as pelvic surgery in the management of endometrial cancer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article